Unknown

Dataset Information

0

Point Mutation Specific Antibodies in B-Cell and T-Cell Lymphomas and Leukemias: Targeting IDH2, KRAS, BRAF and Other Biomarkers RHOA, IRF8, MYD88, ID3, NRAS, SF3B1 and EZH2.


ABSTRACT: B-cell and T-cell lymphomas and leukemias often have distinct genetic mutations that are diagnostically defining or prognostically significant. A subset of these mutations consists of specific point mutations, which can be evaluated using genetic sequencing approaches or point mutation specific antibodies. Here, we describe genes harboring point mutations relevant to B-cell and T-cell malignancies and discuss the current availability of these targeted point mutation specific antibodies. We also evaluate the possibility of generating novel antibodies against known point mutations by computationally assessing for chemical and structural features as well as epitope antigenicity of these targets. Our results not only summarize several genetic mutations and identify existing point mutation specific antibodies relevant to hematologic malignancies, but also reveal potential underdeveloped targets which merit further study.

SUBMITTER: Singh K 

PROVIDER: S-EPMC8065453 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4643045 | biostudies-literature
| S-EPMC2923633 | biostudies-literature
| S-EPMC7706582 | biostudies-literature
| S-EPMC8468625 | biostudies-literature
| S-EPMC310834 | biostudies-literature
| S-EPMC6425375 | biostudies-literature
| S-EPMC9599435 | biostudies-literature
| S-EPMC7179762 | biostudies-literature
| S-EPMC10653050 | biostudies-literature
| S-EPMC10664184 | biostudies-literature